Goldspan Health Review: Price, Pros & Cons
Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company.
In this review
Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.
Prices at a glance
- Semaglutide
- $229 every 28 daysMonth-to-month (13 charges a year, not 12)
- Tirzepatide
- $299 every 28 daysMonth-to-month (13 charges a year, not 12)
- Coverage
- All 50 states
- Brand-name
- Not confirmed
Semaglutide · estimated annual cost
$2,977
13 charges a year: billed every four weeks
Tirzepatide · estimated annual cost
$3,887
13 charges a year: billed every four weeks
Who Goldspan Health may suit
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Where the value is
- Prices ten GLP-1 products openly before any account — standard injections with a B12 or glycine base, plus low-dose injections and daily sublingual microdoses
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
- Names a medical director and two clinical advisors with their specialties
- Says which pharmacy classes dispense — licensed 503A or 503B pharmacies — even though it does not name the pharmacy
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy saying all sales are final once an order is placed, with a full refund only if the clinician declines to prescribe
- The tirzepatide low-dose sublingual page lists "Compounded sublingual semaglutide microdose" among what the price includes — the wrong molecule on a product page
- No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
- The certification seal shown belongs to the storefront operator, not to Goldspan Health itself
- "IN 50 STATES" on the homepage sits against terms saying some therapies are unavailable in certain states, with no list either way
- The weight-loss page lists injections only; the lower-priced microdose and sublingual versions sit under a separate inflammation category
What Goldspan charges
Goldspan Health sells compounded semaglutide at $229 and compounded tirzepatide at $299. Both are billed every 28 days, not once a calendar month, so a year is 13 charges. That makes a year of semaglutide $2,977 and a year of tirzepatide $3,887. There's one plan, month to month, and no prepay discount.
The plan card spells out what the price covers: the clinician's evaluation and prescription, the medication, syringes and alcohol pads, two-day shipping each month, and access to a board-certified clinical team for questions and dose changes. Each drug comes in two versions, one compounded with B12 and one with glycine. Lower-dose "microdose" versions, including sublingual ones, are listed separately under Goldspan's inflammation category.
Budget for one more cost. A lab panel is required 60 to 90 days after you start and once a year after that. Goldspan offers it at what it calls a low cost through a lab center near you, without publishing the price, or you can have your own doctor run it and upload the results.
Considering Goldspan Health?
Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.
Who's behind the prescription
Goldspan is the brand. The checkout, the clinical care and the prescriptions all run through Altro Health, a separate company whose storefront you land on when you click to order. Goldspan names Altro's clinicians on its about page: Dr. Hinds, the medical director, who is board certified in obesity medicine, plus two clinical advisors, Dr. Butte in internal medicine and Dr. Morse in OB-GYN and menopause care. It notes they belong to an independent medical group, not Goldspan's staff.
Medication is compounded by licensed 503A or 503B pharmacies, which Goldspan doesn't name. It says it never sells research-use-only products.
From order to refill
You order first, then complete a health history and goals questionnaire. The clinical team reviews it within one to two business days. Depending on your history and your state, a clinician may book a 15-minute video visit. The pharmacy takes a few days to prepare the order, and it ships by two-day delivery, so the first box usually arrives about a week after you order.
After that, the order renews every four weeks, with payment taken and the next box shipped automatically. An optional monthly check-in lets your clinician adjust your dose.
Refunds and canceling
Goldspan's refund policy says all sales are final once an order is placed. The one exception is if the clinician reviews your intake and declines to prescribe. Then you get a full refund. If a shipment is lost or damaged, email support within seven days of delivery for a replacement.
The plan card says you can pause, delay or cancel anytime. Do it before your next 28-day renewal, since a processed order can't be refunded. Goldspan says it serves all 50 states.
The Index scorecard
Goldspan Health scored on our six Cost-Efficiency Index factors. See the methodology.
The bottom line
Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company.
Compare the total cost of other GLP-1 programs and alternatives to Goldspan Health before deciding. A clinician should help you choose the right treatment.
Other programs to compare with Goldspan Health
These are partners: we may earn a commission if you sign up, at no cost to you.
CoreAge RxPartner
Semaglutide modeled $99/mo · Tirzepatide modeled $149/mo
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
EdenPartner
Semaglutide modeled $99/mo · Tirzepatide modeled $129/mo
Eden charges $99 a month for compounded semaglutide and $129 for compounded tirzepatide, the same at every dose, with the visit, medication and shipping included.
FoundPartner
Semaglutide modeled $215.58/mo · Tirzepatide modeled $313.08/mo
Found bundles compounded semaglutide or tirzepatide into a care plan you can pay for with insurance or cash; month to month, semaglutide is $199 insured or $289 cash.
Compare with other providers
The providers whose Cost-Efficiency Index scores sit closest to Goldspan Health's. See the alternatives to Goldspan Health.
- PrideRx— PrideRx is a telehealth membership service that prescribes brand-name Zepbound and the Wegovy and Foundayo pills, with the medication shipped and billed separately by LillyDirect or NovoCare.71/100
- Aspire Health— Aspire Health is a Nebraska-founded telehealth practice that prescribes compounded semaglutide and tirzepatide (made with B3) and brand-name Wegovy and Zepbound, with a published dose-by-dose price list and a named PA/NP team.71/100
- Neuvé Health— Neuvé Health offers standard and microdose GLP-1 injections and oral rapid-dissolve tablets, with medication and clinician review included in its displayed treatment prices.71/100
- altRX— altRx is a compounded GLP-1 telehealth platform run through Usable Health, PC and its affiliated medical practices, offering semaglutide and tirzepatide at a flat 'same price at every dose' rate with no membership fee.70/100
- Zappy Health— Zappy Health (operated by Kare Solutions, LLC, based in La Jolla, CA) is a telehealth platform selling both compounded GLP-1s (semaglutide $249/mo and tirzepatide $349/mo month to month at every dose, less on prepaid plans) and brand pathways to Wegovy and Zepbound.70/100
- Kina— Kina is a menopause-first telehealth platform that also genuinely prescribes GLP-1s for weight management, led by a named clinical lead, Dr. Shannon Arora, PharmD.70/100
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.